Displaying One Session

View
Berlin Hall Industry Satellite Symposium

Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)

Date
02.05.2019
Time
12:00 - 13:00
Location
Berlin Hall
Chairs
  • Diana Lüftner (Berlin, Germany)
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Welcome and introduction (ID 736)

Lecture Time
12:00 - 12:05
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Expanding the evidence base for CDK4/6 inhibitors (ID 737)

Lecture Time
12:05 - 12:25
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

The advancing role of PI3K inhibitors (ID 739)

Lecture Time
12:25 - 12:35
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Considerations for PIK3CA mutations: An interactive discussion (ID 738)

Lecture Time
12:35 - 12:50
Speakers
  • Nicholas C. Turner (London, United Kingdom)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Audience question & answer (ID 740)

Lecture Time
12:50 - 13:00
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Closing remarks (ID 817)

Lecture Time
13:00 - 13:00
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00